Lorlatinib shows unprecedented success in advanced NSCLC
Release Date:
Which drug keeps lung cancer from progressing for over 5 years? Find out about this and more in today's PeerDirect Medical News Podcast.
Lorlatinib shows unprecedented success in advanced NSCLC